| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 09/26/1995 | US5453447 Preparation of stable injectable β-carotene solubilizates |
| 09/26/1995 | US5453442 Chromene derivative |
| 09/26/1995 | US5453354 Method for improving sperm motility |
| 09/25/1995 | CA2145469A1 Disubstituted aminoalkyloxy 3-substituted aromatic steroids used for the preparation of a drug to control fertility, especially male fertility; pharmaceutical compositions containing the same |
| 09/22/1995 | CA2144917A1 Time-released alfuzosin hydrochloride galenical forms |
| 09/21/1995 | WO1995024903A1 The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence |
| 09/21/1995 | WO1995024901A1 Treatment of diabetic nephropathy with valsartan |
| 09/21/1995 | CA2184712A1 Treatment of diabetic nephropathy with valsartan |
| 09/20/1995 | EP0672412A2 Use of 3,4-diphenyl chromans for the manufacture of a medicament for lowering cholesterol levels |
| 09/20/1995 | EP0672058A1 Calcium channel blocking polypeptides from heteropoda venatoria |
| 09/20/1995 | EP0671924A1 Digitalis-like compounds |
| 09/20/1995 | CN1108654A Methods of treating menstrual symtoms and compositions therefore |
| 09/20/1995 | CN1029784C Method of chain combination |
| 09/19/1995 | US5451609 Deacetly moxisylyte |
| 09/19/1995 | US5451608 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovasular system, processes for their preparation and pharmaceutical compositions containing them |
| 09/19/1995 | US5451590 Antiestrogen, benzothiophene derivative, preventing early sexual development |
| 09/19/1995 | US5451589 Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism |
| 09/19/1995 | US5451572 Human relaxin formulation |
| 09/14/1995 | WO1995024466A1 Transforming growth factor alpha h1 |
| 09/14/1995 | WO1995024204A1 Chemical castration |
| 09/14/1995 | WO1995024200A1 Method for treating 5ht2b receptor related conditions |
| 09/14/1995 | CA2185236A1 Method for treating 5ht2b receptor related conditions |
| 09/14/1995 | CA2184583A1 Transforming growth factor alpha h1 |
| 09/13/1995 | EP0671156A1 Cosmetic or pharmaceutical compositions containing liposomes |
| 09/13/1995 | EP0475936B1 Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex |
| 09/13/1995 | CN1108255A Methods of inhibiting the symtoms of premenstrual syndrome/late luteal phase dysphoric disorder |
| 09/13/1995 | CN1108103A Methods of inhibiting turner's syndrome |
| 09/13/1995 | CN1108101A Methods of inhibiting male infertility |
| 09/13/1995 | CN1108100A Methods of inhibiting breast disorders |
| 09/13/1995 | CN1108099A Methods of inhibiting sexual precocity |
| 09/13/1995 | CN1108097A Methods of inhibiting atrophy of the skin and vagina |
| 09/12/1995 | US5449674 Prostaglandin E2 inhibitors |
| 09/08/1995 | WO1995023792A1 Use of imidazole derivatives for treating disorders involving angiotensin receptors at1 and at2, certain such products, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing same |
| 09/08/1995 | WO1995023791A1 Novel tetrasubstituted imidazole derivatives, method for preparing same, resulting novel intermediates, use thereof as drugs, and pharmaceutical compositions containing same |
| 09/08/1995 | WO1995023593A1 Controlled release oxybutynin formulations |
| 09/08/1995 | CA2184112A1 Novel tetrasubstituted imidazole derivatives, method for preparing same, resulting novel intermediates, use thereof as drugs, and pharmaceutical compositions containing same |
| 09/08/1995 | CA2184111A1 Use of imidazole derivatives for treating disorders involving angiotensin receptors at1 and at2, certain such products, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing same |
| 09/06/1995 | EP0669939A1 Somatotropin modifications |
| 09/06/1995 | EP0669833A1 USES OF TGF-$g(b) RECEPTOR FRAGMENT AS A THERAPEUTIC AGENT |
| 09/06/1995 | EP0509027B1 A process to correct and optimize the composition of a feed |
| 09/06/1995 | CN1107857A Cyclic amino acid derivativges |
| 09/06/1995 | CN1107705A Method for increasing libido in post-menopausal women |
| 09/06/1995 | CN1107702A Methods of inhibiting ovarian dysgenesis delayed puberty, or sexual infantilism |
| 09/06/1995 | CN1107699A Treatment of incontinence |
| 09/05/1995 | US5447959 Vitamin A derivatives |
| 09/05/1995 | US5447943 Novel benzopyran derivatives |
| 09/05/1995 | US5447912 Injecting the neuropeptides VIP and PHM and an adrenergic blocking agent |
| 09/05/1995 | CA2010017C Composition for reparation and prevention of fibrotic lesions |
| 09/05/1995 | CA1336911C Serotonin antagonists |
| 09/05/1995 | CA1336891C Use of substituted 3,4-dihydro-2h-benzopyrans as remedies for obstructive functional disorders of the lungs and/or disorders of the efferent urinary passages |
| 09/05/1995 | CA1336889C Treatment of iodine deficiency diseases |
| 09/05/1995 | CA1336886C Phenethanolamine and growth hormone combinations |
| 09/02/1995 | CA2143604A1 Fatty acid derivatives |
| 08/31/1995 | WO1995022980A1 Inhibin compositions and methods of use thereof |
| 08/31/1995 | WO1995022972A1 Rapamycin derivatives |
| 08/31/1995 | WO1995022964A1 Transdermal presentation of nitroglycerin for preventing undesired labour |
| 08/31/1995 | CA2184201A1 Transdermal presentation of nitroglycerin for preventing undesired labour |
| 08/30/1995 | EP0668876A1 Treatment of infertility and enhancement of fertilization capacity in mammalian males |
| 08/30/1995 | EP0668872A1 Calcium channel blocking polypeptides from theraphosidae aphonopelma |
| 08/30/1995 | EP0668860A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses |
| 08/30/1995 | EP0668771A1 Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs |
| 08/30/1995 | EP0668770A1 $g(a)-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY |
| 08/30/1995 | CN1107639A Pyridothiazineacetic acid compound, process for producing the same, and use thereof |
| 08/30/1995 | CN1107473A 4-Arylamino-benzopyran and related compounds |
| 08/30/1995 | CN1107467A 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
| 08/30/1995 | CN1107356A Pharmaceutical composition for prophylaxis and treatment of premature ejaculation |
| 08/30/1995 | CN1107332A Methods of inhibiting CNS problems in postmenopausal women |
| 08/29/1995 | US5446053 Administering raloxifene or derivative |
| 08/29/1995 | CA1336835C Benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds |
| 08/29/1995 | CA1336833C Piperidine derivatives |
| 08/24/1995 | WO1995022546A1 Intracellular signalling mediators |
| 08/24/1995 | WO1995022340A1 Methods for altering fertility |
| 08/24/1995 | WO1995022329A1 Agent for prophylaxis and treatment of thromboxane a2-mediated diseases |
| 08/24/1995 | WO1995022322A1 Sexual steroid-containing transdermal therapeutic systems |
| 08/24/1995 | WO1995022321A1 Desogestrel-containing transdermal application agent |
| 08/24/1995 | DE4405899A1 Mittel zur transdermalen Applikation enthaltend Desogestrel Means for transdermal administration comprising desogestrel |
| 08/24/1995 | DE4405898A1 Transdermale therapeutische Systeme enthaltend Sexualsteroide Transdermal therapeutic systems containing sex steroids |
| 08/24/1995 | CA2183562A1 Intracellular signalling mediators |
| 08/24/1995 | CA2183544A1 Desogestrel-containing transdermal application agent |
| 08/23/1995 | EP0668279A2 6-Azaindole thromboxane synthase inhibitors |
| 08/23/1995 | EP0667784A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
| 08/23/1995 | EP0667769A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia |
| 08/23/1995 | CN1107156A Methods of inhibiting uterine fiberosis |
| 08/23/1995 | CN1107146A A process for preparing a composition containing benzoheterocycles |
| 08/23/1995 | CN1107043A Methods for inhibiting endometriosis |
| 08/22/1995 | US5444081 Treatment of hypertension, congestive heart failure, renal failure, glaucoma |
| 08/22/1995 | US5444080 Hypotensive agents |
| 08/22/1995 | US5443837 Parenterally administering 17-alpha-allyl-4,9,11-estratriene-17beta-ol-3-one to breeding animals |
| 08/19/1995 | CA2142513A1 Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
| 08/17/1995 | WO1995021860A1 Methods for variation of chromatin condensation |
| 08/17/1995 | WO1995021840A1 Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase |
| 08/17/1995 | WO1995021839A1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 08/17/1995 | WO1995021613A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 08/17/1995 | WO1995021608A1 Use of insulin sensitisers for treating renal diseases |
| 08/17/1995 | CA2182986A1 Use of insulin sensitisers for treating renal diseases |
| 08/17/1995 | CA2141506A1 Cosmetic or pharmaceutical compositions containing liposomes |
| 08/16/1995 | EP0667347A1 Beta-carboline thromboxane synthase inhibitors |
| 08/16/1995 | EP0667154A1 Use of flavolignans as adjuvants in the therapy of tumors |
| 08/16/1995 | EP0666856A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| 08/16/1995 | EP0666758A1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |